202 related articles for article (PubMed ID: 15064805)
1. Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides.
Tamamura H; Mizumoto M; Hiramatsu K; Kusano S; Terakubo S; Yamamoto N; Trent JO; Wang Z; Peiper SC; Nakashima H; Otaka A; Fujii N
Org Biomol Chem; 2004 Apr; 2(8):1255-7. PubMed ID: 15064805
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.
Tanaka T; Nomura W; Narumi T; Esaka A; Oishi S; Ohashi N; Itotani K; Evans BJ; Wang ZX; Peiper SC; Fujii N; Tamamura H
Org Biomol Chem; 2009 Sep; 7(18):3805-9. PubMed ID: 19707686
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
[TBL] [Abstract][Full Text] [Related]
4. Geometric diversity through permutation of backbone configuration in cyclic peptide libraries.
Perlman ZE; Bock JE; Peterson JR; Lokey RS
Bioorg Med Chem Lett; 2005 Dec; 15(23):5329-34. PubMed ID: 16213707
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore.
Tanaka T; Tsutsumi H; Nomura W; Tanabe Y; Ohashi N; Esaka A; Ochiai C; Sato J; Itotani K; Murakami T; Ohba K; Yamamoto N; Fujii N; Tamamura H
Org Biomol Chem; 2008 Dec; 6(23):4374-7. PubMed ID: 19005596
[TBL] [Abstract][Full Text] [Related]
6. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
[TBL] [Abstract][Full Text] [Related]
7. N-methylated cyclic pentaalanine peptides as template structures.
Chatterjee J; Mierke D; Kessler H
J Am Chem Soc; 2006 Nov; 128(47):15164-72. PubMed ID: 17117868
[TBL] [Abstract][Full Text] [Related]
8. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
Pak VV; Koo M; Yun L; Kwon DY
J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
[TBL] [Abstract][Full Text] [Related]
9. Self-assembling peptide nanotubes from enantiomeric pairs of cyclic peptides with alternating D and L amino acid residues.
Rosenthal-Aizman K; Svensson G; Undén A
J Am Chem Soc; 2004 Mar; 126(11):3372-3. PubMed ID: 15025434
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
[TBL] [Abstract][Full Text] [Related]
11. High-throughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry.
Joo SH; Xiao Q; Ling Y; Gopishetty B; Pei D
J Am Chem Soc; 2006 Oct; 128(39):13000-9. PubMed ID: 17002397
[TBL] [Abstract][Full Text] [Related]
12. Examination of methodology for the synthesis of cyclic thioether peptide libraries derived from linear tripeptides.
Roberts KD; Ede NJ
J Pept Sci; 2007 Dec; 13(12):811-21. PubMed ID: 17880033
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in retro peptides and proteins--an ongoing topochemical exploration.
Chorev M; Goodman M
Trends Biotechnol; 1995 Oct; 13(10):438-45. PubMed ID: 7546569
[TBL] [Abstract][Full Text] [Related]
14. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
[TBL] [Abstract][Full Text] [Related]
15. Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides.
Chatterjee J; Mierke DF; Kessler H
Chemistry; 2008; 14(5):1508-17. PubMed ID: 18080261
[TBL] [Abstract][Full Text] [Related]
16. Design of bioactive and structurally well-defined peptides from conformationally restricted libraries.
Pastor MT; Mora P; Ferrer-Montiel A; Pérez-Payá E
Biopolymers; 2004; 76(4):357-65. PubMed ID: 15386263
[TBL] [Abstract][Full Text] [Related]
17. Conformationally homogeneous cyclic tetrapeptides: useful new three-dimensional scaffolds.
Glenn MP; Kelso MJ; Tyndall JD; Fairlie DP
J Am Chem Soc; 2003 Jan; 125(3):640-1. PubMed ID: 12526657
[TBL] [Abstract][Full Text] [Related]
18. Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor.
Nakamura GR; Reynolds ME; Chen YM; Starovasnik MA; Lowman HB
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1303-8. PubMed ID: 11830661
[TBL] [Abstract][Full Text] [Related]
19. Cyclic peptide template combinatorial libraries: synthesis and identification of chymotrypsin inhibitors.
Eichler J; Lucka AW; Houghten RA
Pept Res; 1994; 7(6):300-7. PubMed ID: 7888713
[TBL] [Abstract][Full Text] [Related]
20. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.
Meyer SC; Gaj T; Ghosh I
Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
